Skip to main content

Table 1 Correlation of clinicopathological parameters and AIB1 mRNA expression in 185 breast cancer patients

From: Expression of AIB1 protein as a prognostic factor in breast cancer

   AIB1 mRNA (n = 185)  
   low high p-value
Age     
  ≤ 50 59 39  
  > 50 52 35 0.54
Histological type    
  IDC 107 66  
  non-IDC 4 8 0.05
Histological grade    
  well 41 15  
  moderate 47 41  
  severe 23 18 0.05
T stage     
  T1 69 29  
  T2 38 41  
  T3 4 4 0.01
Lymph node metastasis    
  negative 59 46  
  positive 51 28 0.16
Stage     
  T1 48 23  
  T2 41 37  
  T3 19 14  
  T4 3 0 0.13
ER     
  negative 30 27  
  positive 81 47 0.12
PR     
  negative 31 27  
  positive 80 47 0.14
HER2     
  negative 85 53  
  positive 26 21 2.28
AR     
  negative 19 5  
  positive 67 38 0.11
DAX-1     
  negative 25 7  
  positive 61 36 0.08
  1. AIB1: amplified in breast cancer I; IHC: immunohistochemistry; IDC: invasive ductal carcinoma; ER: estrogen receptor; PR: progesterone receptor; and AR: androgen receptor.